ANATOMICAL LOCALIZATION OF ATYPICAL MENINGIOMAS: OUR EXPERIENCE ON 81 PATIENTS

  • A.I. CUCU “Professor Dr. N. Oblu” Clinical Emergency Hospital Iasi
  • Claudia Florida COSTEA “Professor Dr. N. Oblu” Clinical Emergency Hospital Iasi
  • I. POEATA “Professor Dr. N. Oblu” Clinical Emergency Hospital Iasi
  • B. COSTACHESCU “Professor Dr. N. Oblu” Clinical Emergency Hospital Iasi
  • Gabriela Florenta DUMITRESCU “Professor Dr. N. Oblu” Clinical Emergency Hospital Iasi
  • Anca SAVA “Professor Dr. N. Oblu” Clinical Emergency Hospital Iasi
  • Mihaela Dana TURLIUC “Professor Dr. N. Oblu” Clinical Emergency Hospital Iasi

Abstract

Objective: this study aims to assess a possible relationship between the tumor location and the incidence of atypical meningiomas (AMs). Material and methods: from 2010 to 2017, 81 patients with AMs underwent surgical resection. The collected data included: patient age, gender, tumor location, dural venous sinus invasion and tumor laterality (right-left). Results: out of the total of 81 patients with AMs, 45 (55.5%) were female patients and 36 (44.5%) were male patients. The male to female ratio was 1:1.3. The mean age of patients who underwent surgery was 62.1 years. There were identified 61 (75.3%) non-skull base meningiomas and 20 (24.6%) skull base meningiomas. Out of the non-skull base meningiomas, the most frequent ones were located at convexity (41.9%) and parasagittal/falcine (32%). Dural venous sinus invasion was reported as present in 18 (22.2%) patients and as absent in 63 (77.7%) patients. Conclusions: AMs are more frequently reported in the cerebral convexity than in the skull base.

Author Biographies

A.I. CUCU, “Professor Dr. N. Oblu” Clinical Emergency Hospital Iasi

Department of Neurosurgery
“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine
Department of Surgery (II), Ph.D. Student

Claudia Florida COSTEA, “Professor Dr. N. Oblu” Clinical Emergency Hospital Iasi

Department of Ophthalmology
“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine
Department of Surgery (II)

I. POEATA, “Professor Dr. N. Oblu” Clinical Emergency Hospital Iasi

Department of Neurosurgery
“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine
Department of Surgery (II)

B. COSTACHESCU, “Professor Dr. N. Oblu” Clinical Emergency Hospital Iasi

Department of Neurosurgery
“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine
Department of Surgery (II)

Gabriela Florenta DUMITRESCU, “Professor Dr. N. Oblu” Clinical Emergency Hospital Iasi

Department of Pathology

Anca SAVA, “Professor Dr. N. Oblu” Clinical Emergency Hospital Iasi

Department of Pathology
“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine
Department of Morpho-Functional Sciences (I)

Mihaela Dana TURLIUC, “Professor Dr. N. Oblu” Clinical Emergency Hospital Iasi

Department of Neurosurgery
“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine
Department of Surgery (II)

References

1. Louis DN, Scheitauer BW, Budka H, von Deimling A, Kepes JJ. Meningiomas. In: Kleihues P, Cavenee WK (eds). Pathology and Genetics of Tumors of the Nervous System. Lyon: IARC Press, 2000, 176-184.
2. Cucu AI, Costea CF, Carauleanu A, Dumitrescu GF, Sava A, et al. Meningiomas related to the Cher-nobyl irradiation disaster in North-Eastern Romania between 1990 and 2015. Revista de Chimie Bu-charest 2018; 69: 1562-1565.
3. Willis J, Smith C, Ironside JW, Erridge S, Whittle IR et al. The accuracy of meningioma grading: a 10-year retrospective audit. Neuropathol Appl Neurobiol 2005; 31(2): 141-149.
4. Bagshaw HP, Burt LM, Jensen RL, Suneja G, Palmer CA, Couldwell WT, Shrieve DC. Adjuvant radiotherapy for atypical meningiomas. J Neurosurg 2017; 126: 1822-1828.
5. Pasquier D, Bijmolt S, Veninga T, Rezvoy N, Villa S. et al. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys 2008; 71(5): 1388-1393.
6. Pearson BE, Markert JM, Fisher WS, Guthrie BL, Fiveash JB et al. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria. Neurosurg Focus 2008; 24(5): E3.
7. Perry A, Louis D, Scheithauer B, Budka H, Von Deimling A: Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumors of the Central Nervous System. IARC Press: Lyon, 2007; 164-172.
8. Cucu AI, Costea CF, Poeata I, Turliuc DM. Prognostic factors in atypical meningioma. Rom Neurosurg 2017; 31: 165-171.
9. Kane AJ, Sughrue ME, Rutkowski MJ, Shangari G, Fang S et al. Anatomic location is a risk factor for atypical and malignant meningiomas. Cancer 2011; 117(6): 1272-1278.
10. Sade B, Chahlavi A, Krishnaney A, Nagel S, Choi E, et al. World Health Organization Grades II and III meningiomas are rare in the cranial base and spine. Neurosurgery 2007; 61(6): 1194-1198.
11. McGovern SL, Aldape KD, Munsell MF, Mahajan A, DeMonte F, et al. A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base menin-giomas. J Neurosurg 2010; 112(5):925-933.
12. Barthélemy E, Loewenstern J, Konuthula N, Pain M, Hall J, et al. Primary management of atypical meningioma: treatment patterns and survival outcomes by patient age. J Cancer Res Clin Oncol 2018; 144(5): 969-978.
13. Zaher A, Abdelbari Mattar M, Zayed DH, Ellatif RA, Ashamallah SA. Atypical meningioma: a study of prognostic factors. World Neurosurg 2013; 80(5): 549-553.
14. Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. Neuro Oncol 2016; 18: 1-75.
15. Combs SE, Schulz-Ertner D, Debus J, von Deimling A, Hartmann C. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas. Int J Radiat Oncol Biol Phys 2011; 81(5): 1415-1421.
16. Klinger DR, Flores BC, Lewis JJ, Hatanpaa K, Choe K, et al. Atypical Meningiomas: Recurrence, Reoperation, and Radiotherapy. World Neurosurg 2015; 84(3): 839-845.
17. Rogers L, Gilbert M, Vogelbaum MA. Intracranial meningiomas of atypical (WHO grade II) histology. J Neurooncol. 2010; 99(3): 393-405.
18. Kim YJ, Ketter R, Henn W, Zang KD, Steudel WI, Feiden W. Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters. Virchows Arch 2006; 449: 529-538.
19. Roser F, Nakamura M, Bellinzona M, Rosahl SK, Ostertag H, Samii M. The prognostic value of progesterone receptor status in meningiomas. J Clin Pathol 2004; 57(10): 1033-1037.
20. Radu I, Panuţa A, Terinte C, Buna-Arvinte M, Scripcariu D, Scripcariu V. Bilateral Synchronous Male Breast Cancer of Rare Histologic Type. Case Report. Rev Med Chir Soc Med Nat Iasi 2016; 120: 631-634.
21. Moise M et al. Immunohistochemical profile of the estrogen and progesterone receptors in mammary benign lesions. Rev Med Chir Soc Med Nat Iasi 2012; 116: 875-882.
22. Socolov D et al. Immunohistochemistry in endometrial hyperplasia and endometrial adenocarcinoma. Rev Med Chir Soc Med Nat Iasi 2016; 120: 355-362.
23. Nanda A, Bir SC, Konar S, Maiti T, Kalakoti P, et al. Outcome of resection of WHO Grade II menin-gioma and correlation of pathological and radiological predictive factors for recurrence. J Clin Neurosci 2016; 31: 112-121.
24. Budohoski KP, Clerkin J, Millward CP, O'Halloran PJ, Waqar M et al. Predictors of early progression of surgically treated atypical meningiomas. Acta Neurochir (Wien) 2018; in press.
25. Champeaux C, Houston D, Dunn L. Atypical meningioma. A study on recurrence and disease-specific survival. Neurochirurgie 2017; 63(4): 273-281.
26. Mahmood A, Caccamo DV, Tomecek FJ, Malik GM. Atypical and malignant meningiomas: a clini-copathological review. Neurosurgery 1993; 33: 955-963.
27. Maier H, Ofner D, Hittmair A, Kitz K, Budka H. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 1992; 77(4): 616-623.
28. Russell D, Rubenstein L. Pathology of Tumours of the Central Nervous System. Baltimore, Williams and Wilkins, 1989; 449-532.
29. Morokoff AP, Zauberman J, Black PM. Surgery for convexity meningiomas. Neurosurgery 2008; 63(3): 427-433.
30. Lee JH, Sade B, Choi E, Golubic M, Prayson R. Meningothelioma as the predominant histological subtype of midline skull base and spinal meningioma. J Neurosurg 2006; 105(1): 60-64.
31. Kepes JJ. Presidential address: the histopathology of meningiomas. A reflection of origins and expected behavior? J Neuropathol Exp Neurol 1986; 45(2): 95-107.
32. Figarella-Branger D, Roche PH, Daniel L, Dufour H, Bianco N, Pellissier JF. Cell-adhesion molecules in human meningiomas: correlation with clinical and morphological data. Neuropathol Appl Neurobiol 1997; 23(2): 113-122.
33. Wibom C, Mörén L, Aarhus M, Knappskog PM, Lund-Johansen M, et al. Proteomic profiles differ between bone invasive and noninvasive benign meningiomas of fibrous and meningothelial subtype. J Neurooncol 2009; 94(3): 321-331.
34. Cirmi S, et al. Chemo preventive Agents and Inhibitors of Cancer Hallmarks: May Citrus Offer New Perspectives? Nutrients 2016; 8: E698.
35. Ciubara AB, et al. The composition of bioactive compounds in wine and their possible influence on osteoporosis and on bone consolidation. Revista de Chimie Bucharest 2018; 69(5): 1247-1253.
36. Craciun P, Vicol MC, Turliuc S, Astarastoae V. Autonomy versus paternalism in involuntary admis-sions. Romanian Journal of Bioethics 2012; 10: 92-101.
37. Craciun P, Astarastoae V, Turliuc S, Vicol MC. Non-voluntary admission of patients with mental disorders: ethical and social issues. Revista de Cercetare si Interventie Sociala 2013; 42: 310-319.
38. Decolli Y, Haba D, Petrariu FD, Duma OO, Petcu AE. Improvement of health care for socially disad-vantaged children with cleft lip and palate anomaly by using proper radiologic examinations. Revista de Cercetare si Interventie Sociala 2015; 51: 176-186.
39. Postolica R, Iorga M, Petrariu FD, Azoicai D. Cognitive-Behavioral Coping, Illness Perception, and Family Adaptability in Oncological Patients with a Family History of Cancer. BioMed Research In-ternational Volume 2017, Article ID 8104397, 11 pages, https://doi.org/10.1155/2017/8104397.
40. Kalamarides M, Stemmer-Rachamimov AO, Niwa-Kawakita M, Chareyre F, Taranchon E, et al. Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes. Oncogene 2011; 30(20): 2333-2344.
41. Evans DG, Huson SM, Donnai D, Neary W, Blair V, et al. A genetic study of type 2 neurofibromato-sis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal trans-mission effect on severity. J Med Genet 1992; 29: 841-846.
42. Kros J, de Greve K, van Tilborg A, Hop W, Pieterman H, et al. NF2 status of meningiomas is associ-ated with tumor localization and histology. J Pathol 2001; 194: 367-372.
43. Perry A, Gutmann DH, Reifenberger G. Molecular pathogenesis of meningiomas. J Neurooncol 2004; 70(2): 183-202.
44. Catala M. Embryonic and fetal development of structures associated with the cerebro-spinal fluid in man and other species. Part I: The ventricular system, meninges and choroid plexuses. Arch Anat Cytol Pathol 1998; 46: 153-169.
45. Call CB, Carter KD, Allen R. Meningiomas. EyeRounds.org. August 30, 2011. Available from: http://EyeRounds.org/cases/137-meningiomas.htm
46. Bampoe J, Ranalli P, Bernstein M. Postoperative reversal of complete (monocular) blindness in skull base meningioma: case report. Can J Neurol Sci 2003; 30(1): 72-74.
47. Park JS, Sade B, Oya S, Kim CG, Lee JH. The influence of age on the histological grading of menin-giomas. Neurosurg Rev 2014; 37(3): 425-429.
48. Murphy M, Pykett MJ, Harnish P, Zang KD, George DL. Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Differ 1993; 4: 715-722.
49. Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Selker RG, et al. Laterality of brain tumors. Neu-roepidemiology 2003; 22(2): 130-138.
50. Bornstein RA, Witt NJ. Are right-hemisphere lesions really larger? Lesion size and laterality in men-ingioma patients. Acta Neurol Scand 1984; 69(3): 176-181.
Published
2018-12-27